Assenagon Asset Management S.A. Purchases 15,287 Shares of Innospec Inc. (NASDAQ:IOSP)

Assenagon Asset Management S.A. grew its position in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) by 12.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 135,369 shares of the specialty chemicals company's stock after acquiring an additional 15,287 shares during the period. Assenagon Asset Management S.A. owned about 0.54% of Innospec worth $15,309,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. DekaBank Deutsche Girozentrale bought a new position in shares of Innospec during the first quarter valued at about $66,000. CWM LLC raised its stake in Innospec by 239.6% in the second quarter. CWM LLC now owns 635 shares of the specialty chemicals company's stock worth $78,000 after buying an additional 448 shares in the last quarter. Blue Trust Inc. raised its stake in Innospec by 503.9% in the third quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company's stock worth $96,000 after buying an additional 650 shares in the last quarter. nVerses Capital LLC raised its stake in Innospec by 200.0% in the third quarter. nVerses Capital LLC now owns 900 shares of the specialty chemicals company's stock worth $102,000 after buying an additional 600 shares in the last quarter. Finally, Motco bought a new position in Innospec in the first quarter worth about $132,000. 96.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Innospec from a "strong-buy" rating to a "buy" rating in a research note on Thursday, August 8th.

Innospec Price Performance

IOSP stock traded down $0.09 during trading on Friday, reaching $109.19. The company had a trading volume of 47,945 shares, compared to its average volume of 107,366. Innospec Inc. has a 52 week low of $96.01 and a 52 week high of $133.71. The company has a market cap of $2.72 billion, a P/E ratio of 18.29 and a beta of 1.07. The business has a 50 day moving average of $111.50 and a 200 day moving average of $119.40.

Innospec (NASDAQ:IOSP - Get Free Report) last announced its earnings results on Tuesday, August 6th. The specialty chemicals company reported $1.39 earnings per share for the quarter, beating analysts' consensus estimates of $1.37 by $0.02. Innospec had a net margin of 7.90% and a return on equity of 14.15%. The business had revenue of $435.00 million during the quarter, compared to the consensus estimate of $468.73 million. During the same quarter last year, the firm earned $1.28 earnings per share. The business's revenue for the quarter was down 9.5% on a year-over-year basis. Research analysts expect that Innospec Inc. will post 5.92 earnings per share for the current year.

Insider Buying and Selling at Innospec

In other Innospec news, CFO Ian Cleminson sold 6,602 shares of the firm's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $113.60, for a total transaction of $749,987.20. Following the completion of the transaction, the chief financial officer now owns 16,394 shares of the company's stock, valued at approximately $1,862,358.40. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.52% of the company's stock.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.